Hong Kong Healthcare Stocks Split: Far Eastern Pharma's FDA Gamble vs. Real Estate QuagmireGlobal Report·Oct 28, 2026 at 10:14 AM01515-2.02%008530.00%
Hong Kong Hospital Stocks Have a New Script: Buybacks and ExitsGlobal Report·Oct 28, 2026 at 09:42 AM060780.00%01515-2.02%
Hong Kong Mid-Caps Boost Buybacks and Dividends Amid Market VolatilityGlobal Report·Oct 20, 2026 at 10:15 AM00596-1.39%01066-3.05%
Special Dividends and Insider Buying Carry Hong Kong's Small-Cap TailGlobal Report·Oct 6, 2026 at 10:48 AM01515-2.02%02630+1.06%
State Capital Injection Ignites Restructuring Wave Across Hong Kong Small-CapsGlobal Report·Oct 6, 2026 at 09:17 AM01339-0.78%01359+0.58%
Hong Kong's Niche Stocks Navigate Sector Shifts: Shipbuilding Backlogs, Healthcare Exits, and GLP-1 BreakthroughsGlobal Report·Sep 29, 2026 at 09:15 AM00317+0.95%00881-2.47%
China Resources Medical Wins Key Court Ruling in Yan Hua IOT DisputeTip Ranks·Sep 14, 2026 at 01:09 PM01515-2.02%
Earnings Diverge as China Tech Group Swings to Profit While Auto and Web3 LanguishGlobal Report·Sep 8, 2026 at 11:32 AM01515-2.02%01780+2.27%
Peripheral Equities Signal Structural Shifts in Capital AllocationGlobal Report·Sep 8, 2026 at 09:18 AM01515-2.02%01780+2.27%
HK Niche Sectors Diverge as MedTech Beats and Biotech Lags in 2026Global Report·Sep 1, 2026 at 11:33 AM02788-6.06%01858-0.28%
Where the Money Goes: 10 Cross-Sections of Hong Kong’s Fragmented LiquidityGlobal Report·Sep 1, 2026 at 10:13 AM01199+0.96%01515-2.02%
Fragmented Recovery: Cross-Border Dynamics Highlight Hong Kong's Hidden DivergenceGlobal Report·Sep 1, 2026 at 09:18 AM02178-12.67%01858-0.28%
China Resources Medical Declares Interim Dividend for First Half of 2026Tip Ranks·Aug 25, 2026 at 03:17 PM01515-2.02%